BMO cuts Acadia Pharmaceuticals stock price target on trial miss By Investing.com - Investing.com UK

Source: Investing.com UK · 2026-09-24T17:04:00+00:00

BMO cuts Acadia Pharmaceuticals stock price target on trial miss By Investing.com Investing.com UK

BestAIBroker analysis

Finance-aware sentiment: negative (-0.50 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 32/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: ACAD, BMO, UK.